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Background: Purifying stem cells is an inevitable process for further investigation and cell-therapy. Sorting side
population (SP) cells is generally regarded as an effective method to enrich for progenitor cells. This study was to
explore whether sorting SP could enrich for the Musashi1 (Msi1) positive cells from Msi1 high expression cells
(Msi1
high cells) derived from mouse embryonic stem cells (ESCs) in vitro.
Results: In this study, Msi1
high cell population derived from ESCs were stained by Hoechst 33342, and then the SP
and non-SP (NSP) fractions were analyzed and sorted by fluorescence activated cell sorter. Subsequently, the
expressions of Msi1 and other markers for neural and intestinal stem cells in SP and NSP were respectively
detected. SP and NSP cells were hypodermically engrafted into the backs of NOD/SCID mice to form grafts. The
developments of neural and intestinal epithelial cells in these grafts were investigated. SP fraction was identified
and isolated from Msi1
high cell population. The expression of Msi1 in SP fraction was significantly higher than that
in NSP fraction and unsorted Msi1
high cells (P< 0.05). Furthermore, the markers for neural cells and intestinal
epithelial cells were more highly expressed in the grafts from SP fraction than those from NSP fraction (P< 0.05).
Conclusions: SP fraction, isolated from Msi1
high cells, contains almost all the Msi1-positive cells and has the
potential to differentiate into neural and intestinal epithelial cells in vivo. Sorting SP fraction could be a convenient
and practical method to enrich for Msi1-positive cells from the differentiated cell population derived from ESCs.
Background
Embryonic stem cells (ESCs) are pluripotent cells
derived from the inner cell mass of the mammalian
blastocyst with self-renewal capacity and multi-develop-
mental plasticity, which makes ESCs a powerful tool for
cell-based therapy [1,2]. Several lines of evidence con-
firmed that under appropriate conditions, ESCs could be
induced to differentiate into pancreatic beta-cells, liver
cells, myocardial cells, hematopoietic cells, and neural
stem cells [3-9]. However, these strategies generally pro-
duced the desired cells only within heterogeneous cell
populations, including pluripotent stem cells and unde-
sired ESC derivatives. The transplantation of the cell
population into tissues is inevitably associated with for-
mation of teratomas, impeding the application of ESC-
based therapies in clinic [10-12]. Recent studies revealed
that the formation of teratomas was not observed after
transplanting purified progenitor cells derived from
ESCs [13-17]. These findings indicated that differentiat-
ing and purifying ESC-derived cells in vitro could be a
strategy that renders ESCs safe and effective in clinic.
It has been reported that mouse ESCs had the poten-
tial to differentiate into a gut-like structure and neural
cells in vitro [18,19]. Musashi1 (Msi1), expressed in the
cytoplasm and nucleus of cells, is an important marker
for intestinal epithelial stem cells (IESCs) and neural
stem cells (NSCs) [20-22]. In our recent study, we had
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(Hes1) high-expression cells (Msi1
highHes1
high cells)
derived from mouse ESCs could develop into small
intestinal epithelial cells, which enhanced the repair of
small intestinal injury in vivo [23]. Furthermore, to pur-
ify the Msi1-positive cell, we constructed a GFP reporter
plasmid vector driven by Msi1-specific promoter
(pMsi1-GFP vector) [24]. Although the pMsi1-GFP vec-
tor can be used to mark Msi1-positive cells from a cell
population, the isolation process is quite complicated
and depends on a cell transfection technique, which
restricts its application. Therefore, a more convenient
and practical separation strategy should be established
for the further investigation of Msi1-positive cells.
Side population (SP) analysis, a widely used flow cyto-
metry assay, based on the ability of cells to efflux fluor-
escent DNA-binding dye Hoechst 33342, can identify
stem cells in tissues, and is a method which opens up
the potential to further enrich stem cells within hetero-
geneous populations [25]. SP was first identified and
sorted from bone marrow by fluorescence activated cell
sorter (FACS) as a distinct cell population highly
enriched for hematopoietic stem cells and endowed with
long-term repopulating capacity [26]. Since this discov-
ery, an increasing number of studies have shown that an
analogous SP fraction has been identified in a variety of
tissues with high levels of stem-like gene expression and
multipotent differentiation potential [27-35]. The use of
SP analysis was also described to isolate a putative stem
cell population from mouse small intestine, and Msi1
was highly expressed in the SP fraction [36]. This sug-
gested that SP sorting could be an effective method to
enrich for progenitor cells, especially in the absence of
definitive cell-surface marker.
In this study, our objective was to establish a practical
process to enrich for the Msi1 positive cells from Msi1
high-expression cell (Msi1
high cell) population derived
from mouse ESCs in vitro.
Methods
Maintenance of mouse ESCs and embryonic bodies (EBs)
formation
The mouse ESC line, ES-E14TG2a (40, XY) was main-
tained without feeder cells in Dulbecco’s Modified Eagle
Medium (DMEM; high glucose; GIBCO BRL, USA) sup-
plemented with 10% fetal calf serum (FCS; Hyclone,
USA), 10 mM HEPES (GIBCO BRL, USA), 0.12%
sodium bicarbonate, 0.1 mM nonessential amino acids
(Hyclone, USA), 0.1 mM 2-mercaptoethanol (2ME;
GIBCO BRL, USA), 100 U/mL penicillin G, 100 μg/mL
streptomycin, and 1000 U/mL leukemia inhibitory factor
(LIF; Chemicon, USA). Subsequently, ESCs were cul-
tured by the hanging-drop method (32 μlp e rd r o p )t o
form EBs at a concentration of 1 × 10
6 cells/ml in EB
medium that consisted of high glucose DMEM supple-
mented with 10% FCS, 10 mM HEPES, 0.12% sodium
bicarbonate, 0.1 mM nonessential amino acids, 0.1 mM
2ME, 100 U/mL penicillin G, and 100 μg/mL streptomy-
cin. ESC and EB cultures were maintained in a humidi-
fied chamber in a 5% CO2-air mixture at 37°C.
Differentiation of Msi1
high cells
Five-day EB cells were dissociated with trypsin (0.25%)/
EDTA and seeded on 6-well culture plates (Nunc, USA)
with a concentration of 1 × 10
5 cells/well. Subsequently,
the cultured EB cells were induced by a serum-free
medium (EGF medium) that consisted of high glucose
DMEM supplemented with 10% Knockout™ serum
replacement (KSR; Invitrogen Corporation, USA), 40
ng/mL EGF (CHEMICON International, USA), 10 mM
HEPES, 0.12% sodium bicarbonate, 0.1 mM nonessential
amino acids, 0.1 mM 2ME, 100 U/mL penicillin G, and
100 μg/mL streptomycin. The dissociated EB cells syn-
chronously cultured in serum-free control medium
without EGF (SF medium) and DMEM medium with
10% FCS (FCS medium) were treated as control groups.
Real-time quantitative RT-PCR
Total RNA was extracted using TRIzol
® Reagent (Invi-
trogen Corporation, USA). The concentration of isolated
total RNA was calculated from the absorbance at 260
nm obtained using a UV-2450 spectrophotometer (Shi-
madzu, Japan). To generate cDNA, 1 μgo ft o t a lR N A
was reverse-transcribed using a ReverTra Ace-a-
® kit
(Toyobo Bio-Technology, Japan). Real-time PCR was
performed using a Real-time™ PCR Master Mix kit
(Toyobo Bio-Technology, Japan) on a Rotor-Gene 6000
detector (Corbett Research, Mortlake, Australia) accord-
ing to the manufacturer’s instructions. The primers
were designed (forward and reverse): mouse Msi1, 5’-
T A GT T CG A GG G AC A GG C TC T - 3 ’ and 5’-G T T
GAG GGA CAG GCA GTA GC-3’; mouse Hes1, 5’-
GGA GAG GCT GCC AAG GTT TT-3’ and 5’-G C A
AAT TGG CCG TCA GGA-3’; mouse leucine rich
repeat containing G protein coupled receptor 5 (Lgr5),
5’- CAC CAG CTT ACC CCA TGA CT-3’ and 5’- CTC
CTG CTC TAA GGC ACC AC-3’; mouse achaete-scute
complex homolog 2 (Ascl2), 5’-G G TG A CT C CT G G
TGG ACC TA-3’ and 5’- TCC GGA AGA TGG AAG
ATG TC-3’;m o u s eB m i 1 ,5 ’- TGT CCA GGT TCA
CAA AAC CA-3’ and 5’- TGC AAC TTC TCC TCG
GTC TT-3’; mouse Nestin, 5’- CCA GAG CTG GAC
TGG AAC TC-3’ and 5’- ACC TGC CTC TTT TGG
TTC CT-3’; mouse SRY-box containing gene 2 (Sox2),
5’- AAG GGT TCT TGC TGG GTT TT-3’ and 5’-
AGA CCA CGA AAA CGG TCT TG -3’; mouse 18S
ribosomal RNA, 5’- GCT AGG AAT AAT GGA ATA
GG-3’ and 5’- ACT TTC GTT CTT GAG GAA TG-3’.
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ribosomal RNA as the constitutive marker [37].
Immunocytochemistry for Msi1
The immunostaining for Msi1 was performed using an
UltraSensitive™ S-P kit (Maxin, Fuzhou, China). The
fixed cells were treated with normal goat serum for 15
min at 37°C and then were incubated with rabbit anti-
mouse Msi1 polyclonal antibody (CHEMICON Interna-
tional, USA) at a 1:200 dilution. Cells were incubated
with biotin-conjugated secondary antibody for 20 min at
37°C, and streptavidin-alkaline phosphatase complex was
applied for 15 min at 37°C after a wash with PBS. After a
15 min PBS wash, the sections were subsequently incu-
bated in 3,3’-diaminobenzidine tetrahydrochloride (DAB;
B o s t e r ,W u h a n ,C h i n a )w i t h0 . 0 5 %H 2O2 for 5 minutes,
and counterstained with hematoxylin for 12 seconds.
Analysis and sorting of SP fraction in Msi1
high cells
SP analysis of the differentiated cells cultured in SF-EGF
medium, FCS medium and SF medium was performed
using the Hoechst 33342 staining method by FACS out-
l i n e db yG o o d e l le ta la n dP a r ke ta l[ 3 8 , 3 9 ] .T h e
detected cells were resuspended in 0.1 M PBS contain-
i n g2 %F C Sa tad e n s i t yo f1×1 0
6 cells/mL and incu-
bated with 5 μg/mL Hoechst 33342 (Sigma-Aldrich,
USA) for 90 minutes at 37°C. To determine the verapa-
mil-sensitive SP cells, partial cells were preincubated
with verapamil (50 μM) for 5 minutes before the addi-
tion of Hoechst 33342 dye. Immediately after staining,
the cells were centrifuged at 1000 rpm for 5 minutes at
4°C and resuspended in ice-cold 0.1 M PBS containing
2% FCS to a concentration of 1 × 10
6 cells/100 μL.
After resuspending, propidium iodide (PI; Sigma-
Aldrich, USA) was added at 2 μg/mL to gate out dead
cells, and the cells were kept at 4°C until analysis and
sorting. A 350 nm argon laser was used to excite
Hoechst 33342 and PI. The cells were analyzed on a
Beckman Coulter EPICS ALTRA cytosorter (Beckman
Coulter, USA) at 405/30 nm (Hoechst blue) and 670/30
nm (Hoechst Red) according to the method described
previously by Goodell et al [38]. Cells were then dis-
played in a Hoechst Blue versus Hoechst Red dot plot
to visualize the SP cells. The SP fraction was identified
and selected by gating on the characteristic emission
fluorescence profile of SP cells. Data were recorded
using EXPO32 MultiCOMP v1.1C and analyzed using
EXPO32 analysis v1.2B. Sorted SP and non-side popula-
tion (NSP) fractions were recovered in 0.1 M PBS with
10% FCS for subsequent investigation.
RT-PCR analysis
Total RNA was extracted from tissues or cells using
TRIzol
® Reagent according to the manufacturer’s
protocol. Total RNA (2 μg) was reverse-transcribed into
first-strand cDNA with Oligo d(T)18 primers (TaKaRa
Bio Inc., Tokyo, Japan) using a PrimeScript™ 1st Strand
cDNA Synthesis kit (TaKaRa Bio Inc., Tokyo, Japan).
PCR was performed with TaKaRa Ex Taq HS (TaKaRa
Bio Inc., Tokyo, Japan) in PCR buffer and 0.5 μM
dNTPs. The PCR cycling conditions were as follows: 1
cycle of 94°C for 1 minute; 35 cycles of 94°C for 30 sec-
onds, 59°C for 30 seconds, 72°C for 1 minute; and 1
cycle of 72°C for 10 minutes. b-actin was used as the
invariant control.
The sequences of primers used in this study are as fol-
lows (forward and reverse): mouse b-actin, 5’-GTC CAC
CTT CCA GCA GAT GT-3’ and 5’-CCT GGG CCA
TTC AGA AAT TA-3’; mouse ATP-binding cassette
transporter G2 (ABCG2), 5’-TCG CAG AAG GAG
ATG TGT TG-3’ and 5’-TTG GAT CTT TCC TTG
CTG CT-3’;m o u s eN e s t i n ,5 ’- GAG AAG ACA GTG
AGG CAG ATG AGT TA -3’ and 5’- GCC TCT GTT
CTC CAG CTT GCT -3’; mouse Tubulin b III, 5’- CTT
CGG GCA GAT CTT CAG AC -3’ and 5’-A G TC A A
CCA GCT CTG CAC CT -3’; mouse sucrase-isomaltase
(SI), 5’-GGG TCC AGC TTT TAT GGT GA-3’ and 5’-
TAT GTG TTC TGT GCC GGT TC-3’;m o u s ef a t t y
acid binding protein 2 (Fabp2), 5’-C A CA G CT G A
GAT CAT GGC ATT C -3’ and 5’- CCA TCC TGT
GTG ATT GTC AGT TTC -3’; mouse trefoil factor 3
(Tff3), 5’-CTC TGT CAC ATC GGA GCA GTG T-3’
and 5’- T T GG C CA C CA T CA G CA G CA G - 3 ’;m o u s e
lysozyme 1 (Lyz1), 5’-GCA GTG CTC TGC TGC AGG
AT-3’ and 5’-GTC AGA CTC CGC AGT TCC GA-3’;
mouse Chromogranin A (ChgA), 5’-CTG ACC GCT
CCA TGA AGC TCT-3’ and 5’-CCT ACT CGA GCA
GCA GTC T-3’. The integrated intensity for the bands
was determined by scanning densitometry and analyzed
by Glyko BandScan 5.0. The data were analyzed using
relative intensity with b-actin as the constitutive marker.
Western blots analysis
The samples for Western blots analysis were sorted SP
and NSP cells by FACS. All cells were incubated in
RIPA lysis buffer: 50 mM Tris, 150 mM NaCl, 1% Tri-
ton X-100, 1% sodium deoxycholate, 0.1% SDS, 2 mM
EDTA, and protease inhibitors (pH 7.4). Total protein
in the supernatant of the cell lysate was measured by
BCA Protein Assay Kit (Beyotime Institute of Biotech-
nology, Haimen, China). Protein (40 μg per sample) was
separated by SDS-PAGE with a 12% polyacrylamide gel.
The protein was transferred electrophoretically onto a
PVDF membrane and incubated primary antibodies
diluted in blocking buffer (5% milk powder, 0.1% Tween
20 in TBS) as follows: rabbit anti-mouse Msi1 antibody
(1:500, CHEMICON International, USA) and rabbit
anti-mouse b-actin antibody (1:1000, Cell Signaling
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horseradish peroxidase-conjugated anti-rabbit antibody
(1:2000). Msi1 and b-actin protein were detected by
ECL chemiluminescence system. The integrated inten-
sity for the protein bands was determined by scanning
densitometry and analyzed by Glyko BandScan 5.0. The
data were analyzed using relative intensity with b-actin
as the constitutive marker.
Grafts
The suspended SP and NSP cells sorted by FACS (1.5 ×
10
6 per administration) were hypodermically engrafted
into the backs of NOD/SCID mice (Laboratory Animal
Center of Sun Yat-Sen University, Guangzhou, China).
All experimental procedures involving mice in this study
were approved by the Animal Ethics Committee of the
second affiliated hospital of Sun Yat-Sen University.
When the hypodermic grafts were generated, the mice
were sacrificed and the grafts were investigated by histo-
logical, immunohistochemical, and RT-PCR analysis.
Immunohistochemistry
The grafts were removed from NOD/SCID mice and
fixed with 4% paraformaldehyde overnight at 4°C,
embedded in paraffin, and cut at a thickness of 6 μm.
The sections were placed in 0.01 M citrate buffer (pH
6.0) and treated in the microwave oven for 10 min to
facilitate antigen retrieval. Following treatment with 3%
H2O2, sections were placed in methanol for 10 min to
quench endogenous peroxidase activity, and the immu-
nostaining was performed using an UltraSensitive™ S-P
kit (Maxin, Fuzhou, China). All sections were incubated
with normal goat serum for 10 min at room tempera-
ture, and then were incubated overnight at 4°C with
rabbit anti-mouse Tubulin b III (2.5 mg/mL in PBS; Epi-
tomics, USA) and rabbit anti-mouse Fabp2 (5 mg/mL in
PBS; Abcam, Cambridge, UK), respectively. Subse-
quently, the sections were incubated with biotin-conju-
gated secondary antibody for 12 min at room
temperature. After a PBS wash, a streptavidin-peroxidase
complex was applied for 10 min at room temperature.
After a 15 min PBS wash, the sections were subse-
quently incubated in DAB (Boster, Wuhan, China) with
0.05% H2O2 for 6 minutes, and counterstained with
hematoxylin for 30 seconds.
Statistical analysis
All analyses were performed with a statistical software
package (SAS 8 for Windows; SAS Institute; Cary, NC,
USA). All data in this experiment were presented as the
mean ± standard error (SE). Data were evaluated by
one-way ANOVA in which multiple comparisons were
performed by using the method of least significant
difference. Differences were considered significant if the
probability of the difference occurring by chance was
less than 5 in 100 (P< 0.05).
Results
Differentiation of Msi1
high cells in vitro
ESCs were cultured by the hanging-drop method in EB
medium to attain EBs in vitro. On the fifth day of EBs
formation, the dissociated EB cells were adhesively cul-
tured in EGF medium to induce the differentiation of
Msi1
high cells.
Real-time quantitative RT-PCR analysis suggested that
Msi1 was expressed at a low level in ESCs and in 5-day
EBs (Figure 1A). During the induction stage of Msi1
high
cells, the mRNA expression of Msi1 showed an increas-
ing trend. In the 5-day induction stage under EGF
administration, Msi1 mRNA was 66.29 ± 8.38-fold
greater compared with ESCs, and was significantly
higher than that in the other two control groups (SF
and FCS groups; Figure 1A; P< 0.05).
Immunocytochemistry results revealed that a portion
of cells in 5-day induction stage were immunostained
for Msi1 (Figure 1B). In the EGF group, the positive
cells (Msi1
+ cells) were mainly detected in the middle of
cell clones. The percentages of Msi1
+ cells in EGF, SF,
and FCS groups were 21.1% ± 3.11%, 5.93% ± 1.75%,
and 6.3% ± 2.17%, respectively (Figure 1C). The percen-
tage of Msi1
+ cells in the EGF group was significantly
higher than that in two control groups (Figure 1C, P <
0.05). These results indicated that 5-day administration
of EGF (40 ng/mL) could induce the differentiation of
Msi1
high cells in vitro.
SP and NSP portions can be detected in induction stage
population
To enrich for the Msi1 positive cells, the Msi1
high cells
were stained with Hoechst 33342. Subsequently, the SP
fraction was investigated by FACS. The results revealed
that a portion of the cells in the Msi1
high cell population
and control groups were stained weakly (Figure 2A).
Subsequently, prepared cells were analyzed by FACS
and the typical results of dual-wavelength FACS of
viable cells based on the Hoechst fluorescence are
s h o w ni nF i g u r e2 B .A sc a nb es e e ni nF i g u r e2 B( l e f t
row), a distinct SP and NSP were presented in cells
from all three groups. The percentage of SP in the
induction stage cells after 5 days of culture was 19.97%
± 3.76% for EGF (Msi1
high cells), 9.33% ± 2.71% for FS,
and 5.3% ± 0.5% for FCS medium (Figure 2C). Based on
statistical analysis, the SP percentage in Msi1
high cells
was significantly higher than that in SF (P = 0.016 com-
p a r e dw i t hE G Fg r o u p )a n dF C Sc o n t r o lg r o u p s( P =
0.003 compared with EGF group). Although the average
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that of FCS cell population, there was no statistically dif-
ference between them (P = 0.064).
Previous reports describing SP fractions from liver,
mammary gland, and lung have revealed that the SP
phenotype is dependent on efflux of Hoechst 33342 by
multidrug resistance-like pumps, such as ABCG2/
BCRP1 [32,33,40,41]. To investigate whether or not the
SP from differentiated populations derived from ESCs
was caused by analogous efflux of Hoechst 33342, we
treated the detected cell preparations with 50 μM vera-
pamil to inhibit members of the multi-drug resistance
family. This treatment resulted in a 35.9% ± 6.8% reduc-
tion of cells sorting to SP position in EGF group (Msi1-
high cells), and the reduction percentage in SF and FCS
control groups were 49.8% ± 5.9% and 46.5% ± 2.7%,
respectively (Figure 2B, right row). The percentage of SP
reduced by verapamil administration in Msi1
high cells
was significantly higher than that of other two control
groups (Figure 2C, P < 0.05).
Msi1 positive cells can be enriched in SP fraction from
Msi1
high cell population
To explore the hypothesis that Msi1 positive cells can
be enriched in SP fraction from Msi1
high cells, the SP
a n dN S Pc e l l sw e r es y n c h r o n o u s l yi s o l a t e df r o mM s i 1 -
high cell population under a condition without verapamil
(Figure 3A).
Subsequently, as a gene marker for IESCs and NSCs,
the expression of Msi1 was respectively detected in SP
and NSP fractions on mRNA and protein levels. The
results of quantitative RT-PCR revealed that the relative
Figure 1 Specification of Msi1
high cells in vitro derived from mouse ESCs. (A): Relative abundance of mRNA of Msi1 in 5-day EBs (EB, red
bar) and induction stage cells at 5-day in EGF medium (EGF, solid bar), SF medium (SF, gray bar), and FCS medium (FCS, blank bar) compared
with ESCs (ESC, blue bar). Bars show mean ± SE (n = 3) measured by real-time RT-PCR. The red bar indicates that its abundance is 1.0 on these
two scales. (*P< 0.05 compared with all other samples) (B): The immunostaining for Msi1 by immunocytochemistry was detected in partial cells
at the 5-day differentiation cultured in EGF, SF, and FCS medium. (arrowheads; Bar indicates 20 μm in this panel) (C): Percentage of Msi1
+ cells at
the 5-day differentiation cultured in EGF, SF, and FCS medium. (Bar shows mean ± SE in this panel; n = 3 individual experiments; *P< 0.05
compared with all other samples).
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fold and 0.05 ± 0.02-fold greater compared with
unsorted Msi1
high cells (Figure 3B). Western blot analy-
sis was used to compare band intensities of Msi1 with
b-actin as a constitutive marker. Msi1 protein was
detected in SP and NSP fractions (Figure 3C). Integrated
intensity of Msi1 protein in SP fraction was 0.329 ±
0.091, and the Msi1 expression band was not detected
in NSP fraction (Figure 3D). The expression of Msi1 in
SP fraction was significantly higher than that in NSP
fraction and unsorted Msi1
high cells (P < 0.05). Taken
together these results indicated that sorting SP fraction
by FACS could be a valuable method to isolate Msi1
+
cells.
Expressions of other marker genes for IESCs and NSCs
The expressions of other marker genes for IESCs
(Lgr5, Hes1, Bmi1, and Ascl2) and NSCs (Sox2 and
Nestin) in SP and NSP fractions were further investi-
gated [42-46]. The results of quantitative RT-PCR
revealed that the relative mRNA abundance compared
with unsorted Msi1
high cells in SP and NSP fractions
were 4.42 ± 1.38-fold and 0.25 ± 0.06-fold greater for
Lgr5 (Figure 4A); 26.05 ± 3.08 folds and 0.09 ± 0.02-
fold for Hes1 (Figure 4B); 1.98 ± 0.68-fold and 0.52 ±
0.17-fold greater for Bmi1 (Figure 4C); 1.34 ± 0.58-fold
and 0.92 ± 0.32-fold greater for Ascl2 (Figure 4D);
1.21 ± 0.38-fold and 0.89 ± 0.22-fold greater for Sox2
(Figure 4E); and 10.62 ± 2.49-fold and 0.22 ± 0.05-fold
Figure 2 Identification of SP and NSP fractions in Msi1
high cell population by FACS. (A): A part of cells in Msi1
high cell population (EGF)
and control groups (SF and FCS) were presented a relative weak staining after Hoechst 33342 dye. (green arrowheads; Bar indicates 50 μmi n
this panel) (B): FACS analysis showed a typical profile of dual-wavelength FACS of viable cells based on the Hoechst fluorescence. The distinct SP
and NSP fractions were presented in all three groups (EGF, SF, and FCS). The detected cell populations in right row were treated with 50 μM
verapamil (+Verapamil). (C): Percentage of SP cells in Msi1
high cells and two control groups (SF and FCS) with or without verapamil pretreatment
(+Verapamil and -Verapamil). (Bar shows mean ± SE in this panel; n = 3 individual experiments; *P< 0.05 compared with all other groups).
Yu et al. BMC Cell Biology 2011, 12:47
http://www.biomedcentral.com/1471-2121/12/47
Page 6 of 12greater for Nestin (Figure 4F). The expressions of Lgr5,
Hes1, Bmi1, and Nestin in SP fraction were signifi-
cantly higher than those in NSP fraction and unsorted
Msi1
high cells (P<0 . 0 5 ) .
ABCG2 expression in SP and NSP fractions from Msi1
high
cells
Subsequently, total RNA was extracted from SP, NSP,
and unsorted Msi1
high cells, and analyzed by RT-PCR for
ABCG2 (Figure 5A). The relative abundance of ABCG2
mRNA expression was 0.3093 ± 0.0579 in Msi1
high cells,
0.2844 ± 0.0726 in SP group, and 0.3397 ± 0.0938 in NSP
group (Figure 5B). There was no statistical difference
among these three groups in ABCG2 expression. These
results indicated that a similar expression of ABCG2, a
multidrug resistance-like pump, was detected in SP and
NSP fractions sorted from Msi1
high cells.
SP from Msi1
high cells can develop into intestinal
epithelial and neural tissues in vivo
The SP and NSP cells sorted from Msi1
high cells cul-
tured in a DMEM medium supplemented with 15%
FCS. The proliferation of SP and NSP cells in vitro were
observed and assessed by proliferative curve (Figure 6A).
The results showed that SP and NSP cells were
adhesively cultured and presented with similar prolifera-
tive profiles in vitro. To further determine that the sort-
ing SP fraction by FACS was an available method to
enrich for Msi1 positive cells in vitro, SP and NSP cells
sorted from Msi1
high cells were hypodermically
engrafted into the backs of NOD/SCID mice. Two
weeks after injection, grafts were developed with a dia-
meter of 1 to 1.5 cm.
The grafts developed from SP and NSP both con-
tained a mixture of well-differentiated tissues and many
immature cells without specific structure. Abundant
adenoid (AD), neural tube-like (NT), and sack-like
structures were observed in the grafts from SP cells
(Figure 6B). Fibrous tissues, macroscopic cartilages,
nest-like structures, and pigment epithelium were
observed in NSP grafts (Figure 6B).
Because Msi1 is regarded as a marker for IESCs and
NSCs, the development of intestinal epithelial and neural
cells in SP grafts were investigated [21,47,48]. The
mRNA expressions of neural tissue markers (Nestin and
Tubulin b III) and intestinal epithelial cells markers (SI
and Fabp2 for absorptive cells; Tff3 for goblet cells; Lyz1
for Paneth cells; ChgA for endocrine cells) were detected
in grafts from SP and NSP cells by RT-PCR (Figure 6C).
The results revealed that the mRNA relative abundance
was 0.681 ± 0.108 for Nestin, 0.703 ± 0.112 for Tubulin b
III, 0.357 ± 0.061 for SI, 0.634 ± 0.091 for Fabp2, 0.077 ±
0.017 for Tff3, 0.218 ± 0.034 for Lyz1, and 0.068 ± 0.016
for ChgA in SP grafts (Figure 6D, E). The mRNA abun-
dance in NSP grafts was 0.101 ± 0.027 for Lyz1 and 0.072
± 0.017 for ChgA (Figure 6E). The expressions of Nestin,
Tubulin b III, SI, Fabp2, and Tff3 were not detected in
NSP grafts. The statistical analysis revealed that the
mRNA expressions of Nestin, Tubulin b III, SI, Fabp2,
Tff3, and Lyz1 in SP grafts were significantly higher than
that in NSP grafts (P< 0.05). These data indicated that
more neural tissues and small intestinal epithelial cells
were developed in the grafts from SP cells.
To further characterize the developed potential of SP
cells from Msi1
high cells, grafts were immunohisto-
chemically stained with Tubulin b III and Fabp2 to
detect the differentiation of neural and small intestinal
epithelial tissues in vivo. The results showed that the
Tubulin b III positive cells were located in some of non-
specific structures and nest-like structures (Figure 6F).
More Tubulin b III-positive cells were detected in the
grafts from SP cells than in grafts from NSP cells (Fig-
ure 6F). Fabp2 is a marker protein for intestinal absorp-
tive cells. The results revealed that more Fabp2 positive
cells were detected in the grafts from SP cells (Figure
6F). Partial Fabp2 positive cells formed sack-like struc-
tures. These special structures, mostly constructed of
monolayer cells, were similar to the intestinal crypt
structure of fetal mice (Figure 6F). These results
Figure 3 Msi1 expression cells can be enriched in SP fraction.
(A): SP and NSP fractions were synchronically sorted from the
Msi1
high cells by FACS. (B): Relative abundance of mRNA of Msi1 in
SP and NSP fractions sorted from Msi1
high cells compared with
unsorted Msi1
high cells. Bars show mean ± SE (n = 3) measured by
real-time RT-PCR. The mRNA abundance in unsorted Msi1
high cells is
1.0 on these two scales. (*P< 0.05 compared with all other samples)
(C): Expressions of the Msi1 and b-actin proteins in SP and NSP
fractions sorted from Msi1
high cells detected by Western blots. (D):
Protein levels of Msi1 indicated by the integrated intensities of
corresponding bands in panel C (Mean ± SE values, n = 3 individual
experiments). (*P< 0.05 compared with all other samples; N.D
indicates not detected).
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high cells had
similar differentiated potentials with Msi1 positive cells,
which could develop into neural and intestinal epithelial
tissues in vivo [24].
Discussion
The therapeutic potential of ESC-derived stem cells has
been hindered by the formation of teratomas. Purifying
ESC-derived stem cells is a potential approach to over-
come this barrier. SP cells are identified and isolated in
many different tissues, tumors, and cell lines, and are
generally accepted as a unique character for stem cells
[49]. The percentages of SP cells derived from ESCs
range from 1% to 16% of total viable cells, depending on
the stage of ESC development [50]. In the current study,
SP cells were identified and sorted in the induction
s t a g ec e l l sf r o mm o u s eE S C sc u l t u r e di nE G F ,S F ,a n d
FCS medium, and the SP percentage in EGF group was
significantly higher than that in control groups. Con-
sisted with our previous findings showing that EGF can
induce the differentiation of ESCs into Msi1
high cells
and increase the percentage of Msi1 positive cells, 5-day
EGF administration enhanced the percentage of SP cells
(Figure 2C), suggesting that the SP fraction probably
contains a large proportion of stem or progenitor cells
derived from ESCs, including the Msi1 positive cells
[23].
Until recently, it was impossible to isolate IESCs and
NSCs based on identifying any single marker expressed
on the cell surface. As a protein in the cytoplasm and
nucleus required for asymmetric cell division, Msi1 is
expressed in NSCs as well as in IESCs [51]. In our pre-
vious study, the Msi1-positive cells sorted from ESC-
derived cells after a pMsi1-GFP vector transfection had
the potential to differentiate into neural and intestinal
epithelial cells in vivo [24]. However, the isolation pro-
cess is complicated and completely depends on cell
transfection, which restricts its application. It was
reported by Dekaney et al that the SP fraction sorted
from mouse jejunum had the stem-like characters and
highly expressed Msi1 [36]. SP cells sorted from colon
also expressed Msi1, b-integrin, and CD133. Consist
with these previous studies, our results demonstrated
that SP fraction contained almost all Msi1-positive cells
(Figure 3B, D), indicating that sorting SP fraction by
FACS, which is regarded as an effective and convenient
Figure 4 Expressions of other markers for IESCs and NSCs in SP, NSP, and unsorted Msi1
high cells. Relative abundance of mRNA of Lgr5
(A), Hes1 (B), Bmi1 (C), Ascl2 (D), Sox2 (E), and Nestin (F) in SP and NSP fractions compared with unsorted Msi1
high cells. Bars show mean ± SE
(n = 3) measured by real-time RT-PCR. The mRNA abundance in unsorted Msi1
high cells is 1.0 on these scales. (*P< 0.05 compared with all other
samples).
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Page 8 of 12method to enrich for stem or progenitor cells, could be
a reliable method to enrich for Msi1-positive cells from
the differentiated cell population derived from ESCs.
Zhou et al found that ABCG2, a subtype member of
the ATP binding cassette (ABC) transporter, is a mole-
cular determinant of the SP phenotype in mouse bone
marrow [52,53]. Furthermore, ABCG2 expression was
also identified in SP cells sorted from other tissues,
such as skeletal muscle, liver, mammary gland, lung,
and skin [27,30,32,33,41]. These studies demonstrated
that ABCG2 plays an important role in the SP pheno-
type. However, it had become clear that the expression
of ABCG2 was not detected in the all SP cells. The
NSP cells sorted from mouse ESCs expressed Bcrp1 at
a level equivalent to that from the SP fraction [53]. It
was reported by Alt et al that ABCG2 expression was
not detected in the SP cells from human umbilical cord
blood [54]. This discrepancy was also reported in mam-
mary gland cells and haemopoietic cells [55,56]. In our
study, the SP phenotype is partially caused by ABCG2
activity, as evidenced by the marked reduction in SP
cells with the administration of verapamil, an inhibitor
of the ABCG2, which can block the formation of the SP
fraction. The results showed that a similar expression of
ABCG2 between SP and NSP fraction sorted from
Msi1
high cells was detected, indicating that ABCG2
expression is not sufficient to confer the SP phenotype
(Figure 5A, B). Because there is a significant overlap in
the substrate specificity of ABC transporters, with each
of the commonly studied family members ABCG2,
MDR1, and MRP1 being capable of effluxing Hoechst
33342 dye, the mechanism contributing to SP pheno-
type sorted from Msil
high cells should be further investi-
gated [55,56].
Msi1, a marker for NSC and IESC, plays key roles in
the maintenance of the stem cell state and its differen-
tiation, which had been shown by several scholars and
us [20-22,57]. The Msi1 protein can also be found in
tissues from patients with endometriosis and endome-
trial carcinoma, photoreceptor cells, retinal stem cells,
and the hair follicle stem cell nich [58,59]. To confirm
that the SP cells sorted from Msil
high cells had the phe-
notype of NSC and IESC, the expressions of other mar-
kers for IESCs (Lgr5, Hes1, Bmi1, and Ascl2) and NSCs
(Sox2 and Nestin) in SP and NSP fractions were
detected, respectively (Figure 4) [42-46]. The results
revealed that sorting SP fraction could enrich for Lgr5,
Hes1, Bmi1, and Nestin high expression cells, further
indicating that SP cells could have the developed poten-
tials of IESCs and NSCs. Recent studies showed that
IESCs could be grouped into two different phenotypes
[22]. One group presented with Msi1 and Hes1 expres-
sion resides in intestinal crypts near the transit-amplify-
ing cells. Another marked with Lgr5 and Ascl2 resides
between Paneth cells at the small intestinal crypt base.
H o w e v e r ,A s c l 2e x p r e s s i o ni nS Pf r a c t i o nw a ss i m i l a r
with NSP fraction and not consistent with the expres-
sion of Lgr5 (Figure 4A, D). The reason for the inconsis-
tent expression between Lgr5 and Ascl2 is not clear and
should be further investigated.
As mentioned above, the strong expression of Msi1
and other markers for IESCs and NSCs were detected in
SP fraction. SP cells sorted from Msi1
high cells were
engrafted into the NOD/SCID mice to illuminate their
developed profiles compared with NSP cells in vivo. The
results showed that the SP grafts tended to differentiate
into AD-like, NT-like, and sack-like structures (Figure
6A). This pathological profile suggested that SP graft
contained more tissues and structures developed from
NSCs and IESCs. Consistent with this observation, the
expression of neural tissue markers (Nestin and Tubulin
b III) and intestinal epithelial cells markers (Tubulin b
III, SI, Fabp2, Tff3, and Lyz1) were significantly higher
in SP grafts compared with NSP grafts (Figure 6B-6D).
In addition, immunochemistry showed that more Tubu-
lin b III positive cells partially constructed with a nest-
like profile and more Fabp2-positive cells were observed
in the SP grafts (Figure 6E). These results provided
Figure 5 A B C G 2e x p r e s s i o ni nS Pa n dN S Pf r a c t i o n sf r o m
Msi1
high cells. Total RNA was extracted from SP, NSP, and unsorted
Msi1
high cells and analyzed by RT-PCR for ABCG2. (A): RT-PCR
analysis for ABCG2. b-actin served as the control. (B): Relative mRNA
expression of ABCG2 indicated by the integrated intensity of the
corresponding bands in Panels A are shown in this panel. There was
no statistical differentiation in ABCG2 expression among these three
groups. (Mean ± SE; n = 3 individual experiments).
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Page 9 of 12strong evidence that SP cells sorted from Msi1
high cells
had the similar potential of Msi1 positive cells, which
could develop into mature neural and intestinal epithe-
lial tissues in vivo. Because forming grafts in NOD/
SCID mice is a method for investigating the developed
potential of the Msi1-positive cells in vivo, we have not
yet performed the experiments necessary to prove that
the cells isolated from Msi1
high cells will not form tera-
tomas in the mice with normal immune function.
Conclusions
In conclusion, SP was identified and isolated from Msi1-
high cell population derived from ESCs in vitro in this
study. Furthermore, the sorted SP fraction contains
almost all the Msi1 positive cells and has the potential
to differentiate into neural and intestinal epithelial cells
in vivo. Therefore, sorting SP fraction could be a conve-
nient and effective method to enrich for Msi1-positive
cells from the differentiated cell population derived
from mouse ESCs.
Abbreviation
(ESC): embryonic stem cell; (Msi1): Musashi1; (IESC):
intestinal epithelial stem cell; (NSCs): neural stem cells;
(Hes1): hairy and enhancer of split 1; (SP): side popula-
tion; (FACS): fluorescence activated cell sorter; (EB):
Figure 6 SP cells sorted from Msi1
high cells could develop into neural and intestinal epithelial tissues. (A): Proliferative curves of SP and
NSP cells cultured in vitro. (B): Developmental potentials of SP and NSP cells in vivo. Abundant AD-like, NT-like, and sack-like structures were
observed in the grafts from SP cells. Fibrous tissues and nest-like structures were observed in NSP grafts. Bar indicates 25 μm in this panel.
(arrowheads; H&E staining) (C): RT-PCR analysis for the markers of neural cells (Nestin and Tubulin b III) and intestinal epithelium cells (SI, Fabp2,
Tff3, Lyz1, and ChgA). (D): Relative mRNA expressions of Nestin and Tubulin b III are shown in this panel. (Mean ± SE; n = 3 individual
experiments; *P< 0.05 compared with NSP group; N.D indicates not detected) (E): Relative mRNA expressions of SI, Fabp2, Tff3, Lyz1, and ChgA
indicated by the integrated intensity in Panels C. (Mean ± SE; n = 3 individual experiments; *p < 0.05 compared with NSP group; N.D indicates
not detected) (F): Immunostaining for Tubulin b III and Fabp2 in SP and NSP grafts. Tubulin b III positive cells were located in some of non-
specific structures and neural tube-like structures (arrowheads). More Fabp2 positive cells were detected in SP grafts (arrowheads). Partial Fabp2
positive cells formed sack-like structures with a monolayer cell structure (arrow). The special portion was zoomed and magnified. Bar indicates 50
μm in Tubulin b III panels and 100 μm in Fabp2 panels.
Yu et al. BMC Cell Biology 2011, 12:47
http://www.biomedcentral.com/1471-2121/12/47
Page 10 of 12embryonic body; (DMEM): Dulbecco’s Modified Eagle
Medium; (FCS): fetal calf serum; (LIF): leukemia inhibi-
tory factor; (KSR): Knockout™ serum replacement;
(Lgr5): leucine rich repeat containing G protein coupled
receptor 5; (Ascl2): achaete-scute complex homolog 2;
(Sox2): SRY-box containing gene 2; (PI): propidium
iodide; (NSP): non-side population; (ABCG2): ATP-
binding cassette transporter G2; (SI): sucrase-isomaltase;
(Fabp2): fatty acid binding protein 2; (Tff3): trefoil fac-
tor 3; (Lyz1): lysozyme1; (ChgA): Chromogranin A;
(DAB): 3,3’-diaminobenzidine tetrahydrochloride; (SE):
standard error; (AD): adenoid; (NT): neural tube-like;
(ABC): ATP binding cassette.
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